U.K.-Based Riot Labs Earns PMTA Acceptance for E-liquids
Credit: Riot Labs
Riot Labs, a UK-based e-liquid manufacturer has received an acceptance letter from the U.S. Food and Drug Administration (FDA) for its premarket tobacco product application (PMTA). The company is now authorized to sell seven flavors of e-liquids in the United States:
● Pink Grenade
● Sub Lime
● Tropical Fury
● Blue Burst
● Cherry Fizzle
● Rich Black Grape
● Ultra peach Tea
The flavors can be found in 0mg, 3mg and 6mg in freebase nicotine, 20mg and 40mg in nicotine salt. “The PTMA submissions are a key milestone in Riot Labs journey which started back in 2016 to produce viable alternatives to combustible tobacco,” a press release states. “The PMTA submissions conclude a process which has taken over 2 years, with 7 applications and over 1.8 million pages of scientific data submitted as part of the submissions.”
Riot Labs has one year or until the FDA acts on its application to market the products in the U.S.
“We are delighted to announce that our first-round of PMTA applications have been accepted”, said CEO for Ben Johnson Riot Labs. “We pride ourselves on producing the highest quality products. We have been working on our submissions since 2018. Everyone at Riot Labs is fully committed to offering better alternatives to combustible tobacco products.”
Riot Labs was established in 2016 by Johnson who has an extensive background in pharmaceuticals. He set out to build ‘Riot Squad’ into an innovative brand, with safety and sustainability at the forefront of the company’s values, according to the release. By 2019 Riot Squad had moved into the international market, and it’s products were available in over 86 countries.
